Crohn Disease
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Nkx2-3 has been reported to be up-regulated in B cell lines and intestinal tissues from Crohn's disease patients and down-regulated in colorectal cancer.
|
20165982 |
2010 |
Crohn Disease
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Nkx2-3 gene variants are strongly associated with inflammatory bowel disease (IBD) and its expression is up-regulated in Crohn's disease (CD).
|
20188614 |
2010 |
Irritable Bowel Syndrome
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients.
|
21049557 |
2010 |
Crohn Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
NKX2-3 rs10883365 variant allele was associated with increased risk for CD (P = 0.009, OR = 1.24, 95% CI = 1.06-1.48) and UC (P = 0.001, OR = 1.36, 95% CI = 1.13-1.63), whereas variant IRGM allele increased risk for CD (P = 0.029, OR = 1.36, 95% CI = 1.03-1.79).
|
21049557 |
2010 |
Ulcerative Colitis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
NKX2-3 rs10883365 variant allele was associated with increased risk for CD (P = 0.009, OR = 1.24, 95% CI = 1.06-1.48) and UC (P = 0.001, OR = 1.36, 95% CI = 1.13-1.63), whereas variant IRGM allele increased risk for CD (P = 0.029, OR = 1.36, 95% CI = 1.03-1.79).
|
21049557 |
2010 |
Inflammatory Bowel Diseases
|
0.090 |
GeneticVariation
|
group |
BEFREE |
NKX2-3 and IRGM are susceptibility loci for IBD in Eastern European patients.
|
21049557 |
2010 |
Irritable Bowel Syndrome
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
NKX2-3 variant rs11190140 is associated with IBD and alters binding of NFAT.
|
21803625 |
2012 |
Ulcerative Colitis
|
0.400 |
Biomarker
|
disease |
BEFREE |
NKX2-3 may play different roles in UC and CD pathogenesis by differential regulation of EGR1.
|
21968973 |
2012 |
Crohn Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
NKX2-3 may play different roles in UC and CD pathogenesis by differential regulation of EGR1.
|
21968973 |
2012 |
Inflammatory Bowel Diseases
|
0.090 |
AlteredExpression
|
group |
BEFREE |
Nkx2-3 as a transcriptional regulator of MAdCAM-1 controls vascular patterning in visceral lymphoid tissues in mice, and has been identified as a susceptibility factor for inflammatory bowel diseases in humans, associated with lymphoid neogenesis in the inflamed intestines.
|
30891037 |
2019 |
Ulcerative Colitis
|
0.400 |
Biomarker
|
disease |
BEFREE |
A correlation with NKX2-3 and need for surgery (P = 0.038), and with HLA and steroid-responsiveness (P = 0.024) in UC patients was observed.
|
21818367 |
2011 |
Crohn Disease
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
A positive correlation was observed between mRNA expression of PTPN2 and NKX2-3 in B cells and in intestinal tissues from both CD and UC patients.
|
22377701 |
2012 |
Ulcerative Colitis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
A positive correlation was observed between mRNA expression of PTPN2 and NKX2-3 in B cells and in intestinal tissues from both CD and UC patients.
|
22377701 |
2012 |
leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
All together, our study defined a unique lncRNA expression signature associated with ETV6/RUNX1-positive BCP-ALL and identified lnc-RTN4R-1 and lnc-NKX2-3-1 as lncRNAs that might be functionally implicated in the biology of this prevalent subtype of human leukemia.
|
27650541 |
2016 |
Childhood Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
All together, our study defined a unique lncRNA expression signature associated with ETV6/RUNX1-positive BCP-ALL and identified lnc-RTN4R-1 and lnc-NKX2-3-1 as lncRNAs that might be functionally implicated in the biology of this prevalent subtype of human leukemia.
|
27650541 |
2016 |
Ulcerative Colitis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Among these loci, we identified variants in 3p21.31, NKX2-3 and CCNY as susceptibility factors for both diseases, whereas variants in PTPN2, HERC2 and STAT3 were associated only with ulcerative colitis in our sample collection.
|
18438405 |
2008 |
Ulcerative Colitis
|
0.400 |
Biomarker
|
disease |
CTD_human |
Among these loci, we identified variants in 3p21.31, NKX2-3 and CCNY as susceptibility factors for both diseases, whereas variants in PTPN2, HERC2 and STAT3 were associated only with ulcerative colitis in our sample collection.
|
18438405 |
2008 |
Ulcerative Colitis
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
Among these loci, we identified variants in 3p21.31, NKX2-3 and CCNY as susceptibility factors for both diseases, whereas variants in PTPN2, HERC2 and STAT3 were associated only with ulcerative colitis in our sample collection.
|
18438405 |
2008 |
Ulcerative Colitis
|
0.400 |
Biomarker
|
disease |
BEFREE |
An association between NKX2-3 and UC susceptibility was replicated and diverse evidence of epistasis in Japan was suggested.
|
19340882 |
2009 |
Crohn Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
By contrast, variation in the gene encoding the interleukin-23 (IL-23) receptor subunit, as well as in the IL12B, STAT3 and NKX2-3 gene regions, is associated with both Crohn's disease and ulcerative colitis.
|
18500230 |
2008 |
Ulcerative Colitis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
By contrast, variation in the gene encoding the interleukin-23 (IL-23) receptor subunit, as well as in the IL12B, STAT3 and NKX2-3 gene regions, is associated with both Crohn's disease and ulcerative colitis.
|
18500230 |
2008 |
Inflammatory Bowel Diseases
|
0.090 |
GeneticVariation
|
group |
BEFREE |
Consistent with epidemiologic predictions, many IBD-associated loci demonstrate genome-wide significant associations to both CD and UC, notably, genes whose products function in the interleukin-23 pathway, and transcription factors, including NK2 transcription factor related, locus 3 (NKX2-3), SMAD3, STAT3, ZMIZ1, and c-REL.
|
21530736 |
2011 |
Ulcerative Colitis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Consistent with epidemiologic predictions, many IBD-associated loci demonstrate genome-wide significant associations to both CD and UC, notably, genes whose products function in the interleukin-23 pathway, and transcription factors, including NK2 transcription factor related, locus 3 (NKX2-3), SMAD3, STAT3, ZMIZ1, and c-REL.
|
21530736 |
2011 |
Inflammatory Bowel Diseases
|
0.090 |
GeneticVariation
|
group |
BEFREE |
Contribution of NKX2-3 polymorphisms to inflammatory bowel diseases: a meta-analysis of 35358 subjects.
|
24473197 |
2014 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Ectopic overexpression of 10 NKL genes, of which six are unreported in T-ALL (NKX2-3, BARHL1, BARX2, EMX2, LBX2 and MSX2), was detectable in 17/104 (16%) T-ALLs.
|
28592888 |
2018 |